Evidence map›Paper›PMID 26807267›Full record

ArticleFuture science OA

NO supplementation for transfusion medicine and cardiovascular applications.

Pedro Cabrales, Daniel Ortiz, Joel M Friedman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Pedro CabralesDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.
Daniel OrtizDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.
Joel M FriedmanDepartment of Physiology & Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
University of California, San Diego · USAlbert Einstein College of Medicine · US

Funding

New Paradigms in the Design of Blood SubstitutesP01HL071064 · NHLBI · YESHIVA UNIVERSITY · PI FRIEDMAN, JOEL M · 2002 to 2006
$11.8M
Recombinant HbAp Production for In Vivo Toxicity StudiesP01HL110900 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ALAYASH, ABDU I. · 2012 to 2016
$10.6M
BLOOD FLOW AND RHEOLOGY IN THE VENOUS MICROCIRCULATIONR01HL052684 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CABRALES, PEDRO · 1996 to 2011
$3.3M
TRANSFUSION TRIGGER EXTENSION BY PLASMA EXPANDERSR01HL062354 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI INTAGLIETTA, MARCOS · 2000 to 2009
$2.9M
FUNCTIONAL ASPECTS OF OXYGEN DELIVERYR01HL062318 · NHLBI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI INTAGLIETTA, MARCOS · 2001 to 2004
$1.5M
Attenuating the Oxidative and Myocardial Toxicity of Polymerized HemoglobinsR56HL123015 · NHLBI · OHIO STATE UNIVERSITY · PI CABRALES, PEDRO, PALMER, ANDRE FRANCIS · 2014 to 2014
$400k
NHLBI NIH HHS P01 HL071064NHLBI NIH HHS P01 HL110900NHLBI NIH HHS R01 HL052684NHLBI NIH HHS R01 HL062318NHLBI NIH HHS R01 HL062354NHLBI NIH HHS R56 HL123015
6 · The paper itself

Abstract

Blood transfusions are used to treat reduced O

Indexed as

blood transfusionhemorrhagic shockno releasing nanoparticlesred blood cells

Identifiers

PMID26807267
PMCPMC4722959
OpenAlexW2186298884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.